Skip to main content

Table 5 Prevalence per 100 and 95% CIs for the use of stimulants during the year 2000

From: A three-country comparison of psychotropic medication prevalence in youth

 

US (n = 127,157)

Netherlands (n = 110,944)

Germany (n = 356,520)

Age (yr)

Male

Female

Total*

Male

Female

Total*

Male

Female

Total*

0–4

0.76

0.20

0.49

0.08

0.02

0.05

0.02

0.01

0.02

 

0.67–0.86

0.15–0.25

0.48–0.49

0.04–0.14

0.00–0.05

0.04–0.06

0.01–0.04

0.00–0.03

0.01–0.02

5–9

10.72

3.68

7.29

2.86

0.63

1.77

1.74

0.40

1.09

 

10.19–11.26

3.36–4.03

7.28–7.29

2.58–3.16

0.50–0.78

1.76–1.78

1.62–1.87

0.34–0.46

1.08–1.09

10–14

11.43

3.16

7.40

3.57

0.59

2.12

2.37

0.48

1.45

 

10.80–12.07

2.82–3.53

7.39–7.41

3.26–3.9

0.46–0.73

2.11–2.12

2.24–2.50

0.42–0.55

1.45–1.45

15–19

2.75

0.59

1.70

1.17

0.22

0.71

0.42

0.06

0.25

 

2.39–3.16

0.44–0.76

1.69–1.71

1.01–1.35

0.15–0.31

0.70–0.71

0.36–0.48

0.04–0.09

0.24–0.25

Total*

6.52

1.94

4.29

1.95

0.37

1.18

1.16

0.24

0.71

 

6.52–6.53

1.94–1.95

4.29–4.29

1.95–1.96

0.37–0.37

1.18–1.18

1.16–1.16

0.24–0.24

0.71–0.71

  1. *Totals were adjusted to the child and adolescent population of the US 2000 census by the direct standardization method.
Back to article page

Child and Adolescent Psychiatry and Mental Health

ISSN: 1753-2000